Sign inJoin waitlistJoin the waitlist

Yan Ji

Assistant Research Professor · University of Missouri-Columbia School of Medicine

Credentials: · · · · · · · · ·

History

University of Missouri-Columbia School of Medicine
Present

MedStar Union Memorial Hospital
2016–2018
University of Minnesota
2013–2016
MedStar Health
2010–2013
Fudan University
University of Wisconsin-Madison
Tongji Medical University - China
1993–1997

Research

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in…
Clinical Cancer Research · 2022 · 240 citations
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Cancer Research · 2021 · 213 citations
FTO-Dependent N 6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling
Cancer Research · 2020 · 162 citations

Timothy Pluard
5 papers
EJ
Erin Jepsen
4 papers
Gabrielle Rocque
4 papers
JB
Joanne Blum
4 papers
JM
John Migas
4 papers
SL
Shailendra Lakhanpal
4 papers
Manish Patel
3 papers
Meghan Karuturi
3 papers
Robert Kratzke
3 papers
Alexander Dash
2 papers
Daniela Matei
2 papers
ET
Edward Tanner
2 papers

Clinical trials

Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Daehwa Pharmaceutical Co., Ltd.
2018–2022
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2026–2038
Family Communications After Genetic Testing
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2026–2032
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2028